Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 1/20 | 0.57 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.57 |
| ▸ | ITGAL | P20701 | 1/20 | 0.57 |
| ▸ | ITGA4 | P13612 | 17/20 | 0.56 |
| ▸ | ITGB1 | P05556 | 16/20 | 0.56 |
| ▸ | ITGB7 | P26010 | 6/20 | 0.56 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.56 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31445878 | 0.90 | ITGB2 (0.72) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL23489181 | 0.84 | ITGB2 (0.54) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL14532629 | 0.84 | ITGB2 (0.60) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL22983957 | 0.84 | ITGB2 (0.64) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL7545114 | 0.84 | ITGB2 (0.57) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL22983958 | 0.84 | ITGB2 (0.64) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL7410618 | 0.83 | ITGB2 (0.50) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL7544739 | 0.83 | ITGB2 (0.56) | ITGB2ICAM1ITGALITGA4ITGB1 | |
| SCHEMBL7538961 | 0.83 | ITGB1 (0.73) | ITGA4ITGB1ITGB7ITGA2ITGA5 | |
| SCHEMBL2789470 | 0.83 | ITGB1 (0.56) | ITGA4ITGB1ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072539-A1 | AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF | PLIANT THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |